Company intelligence / Profile preview

Asahi Kasei Medical

Chiyoda-ku, Tokyo, Japan

Ownership: Private
Employees: ~1500
Development stage: Other

Overview

Asahi Kasei Medical operates globally in the commercial stage, providing advanced devices and systems for blood treatment, purification, and bioprocessing. The company holds major market shares in hemodialysis, therapeutic apheresis, transfusion therapy, and viral filtration for biotherapeutics, but there are no clinical-stage drug programs as it focuses on commercial medical technologies and devices[1][3][7].

Therapeutic areas: HematologyNephrologyImmunologyOther
Modalities: DeviceBiologicSmall moleculeProtein
Industry: Therapeutic Medical Devices

Partnerships

Virusure (Austria, CRO, acquired 2019)Bionique (U.S., CRO, acquired 2021)Bionova (U.S., CDMO, acquired 2022)

Beyond the preview

Go deeper on Asahi Kasei Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Asahi Kasei Medical.

Explore the full profile